334 related articles for article (PubMed ID: 15010457)
1. Manipulation of alternative splicing by a newly developed inhibitor of Clks.
Muraki M; Ohkawara B; Hosoya T; Onogi H; Koizumi J; Koizumi T; Sumi K; Yomoda J; Murray MV; Kimura H; Furuichi K; Shibuya H; Krainer AR; Suzuki M; Hagiwara M
J Biol Chem; 2004 Jun; 279(23):24246-54. PubMed ID: 15010457
[TBL] [Abstract][Full Text] [Related]
2. Clk/STY (cdc2-like kinase 1) and Akt regulate alternative splicing and adipogenesis in 3T3-L1 pre-adipocytes.
Li P; Carter G; Romero J; Gower KM; Watson J; Patel NA; Cooper DR
PLoS One; 2013; 8(1):e53268. PubMed ID: 23308182
[TBL] [Abstract][Full Text] [Related]
3. The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution.
Colwill K; Pawson T; Andrews B; Prasad J; Manley JL; Bell JC; Duncan PI
EMBO J; 1996 Jan; 15(2):265-75. PubMed ID: 8617202
[TBL] [Abstract][Full Text] [Related]
4. Akt2 regulation of Cdc2-like kinases (Clk/Sty), serine/arginine-rich (SR) protein phosphorylation, and insulin-induced alternative splicing of PKCbetaII messenger ribonucleic acid.
Jiang K; Patel NA; Watson JE; Apostolatos H; Kleiman E; Hanson O; Hagiwara M; Cooper DR
Endocrinology; 2009 May; 150(5):2087-97. PubMed ID: 19116344
[TBL] [Abstract][Full Text] [Related]
5. Combination of Clk family kinase and SRp75 modulates alternative splicing of Adenovirus E1A.
Yomoda J; Muraki M; Kataoka N; Hosoya T; Suzuki M; Hagiwara M; Kimura H
Genes Cells; 2008 Mar; 13(3):233-44. PubMed ID: 18298798
[TBL] [Abstract][Full Text] [Related]
6. SRPK1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors.
Colwill K; Feng LL; Yeakley JM; Gish GD; Cáceres JF; Pawson T; Fu XD
J Biol Chem; 1996 Oct; 271(40):24569-75. PubMed ID: 8798720
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing: a new drug target of the post-genome era.
Hagiwara M
Biochim Biophys Acta; 2005 Dec; 1754(1-2):324-31. PubMed ID: 16260193
[TBL] [Abstract][Full Text] [Related]
8. Human CDC2-like kinase 1 (CLK1): a novel target for Alzheimer's disease.
Jain P; Karthikeyan C; Moorthy NS; Waiker DK; Jain AK; Trivedi P
Curr Drug Targets; 2014 May; 15(5):539-50. PubMed ID: 24568585
[TBL] [Abstract][Full Text] [Related]
9. Autoregulation of the human splice factor kinase CLK1 through exon skipping and intron retention.
Uzor S; Zorzou P; Bowler E; Porazinski S; Wilson I; Ladomery M
Gene; 2018 Sep; 670():46-54. PubMed ID: 29802995
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells.
Bowler E; Porazinski S; Uzor S; Thibault P; Durand M; Lapointe E; Rouschop KMA; Hancock J; Wilson I; Ladomery M
BMC Cancer; 2018 Apr; 18(1):355. PubMed ID: 29606096
[TBL] [Abstract][Full Text] [Related]
11. Novel SR-rich-related protein clasp specifically interacts with inactivated Clk4 and induces the exon EB inclusion of Clk.
Katsu R; Onogi H; Wada K; Kawaguchi Y; Hagiwara M
J Biol Chem; 2002 Nov; 277(46):44220-8. PubMed ID: 12169693
[TBL] [Abstract][Full Text] [Related]
12. Conserved proline-directed phosphorylation regulates SR protein conformation and splicing function.
Keshwani MM; Aubol BE; Fattet L; Ma CT; Qiu J; Jennings PA; Fu XD; Adams JA
Biochem J; 2015 Mar; 466(2):311-22. PubMed ID: 25529026
[TBL] [Abstract][Full Text] [Related]
13. Disordered protein interactions for an ordered cellular transition: Cdc2-like kinase 1 is transported to the nucleus via its Ser-Arg protein substrate.
George A; Aubol BE; Fattet L; Adams JA
J Biol Chem; 2019 Jun; 294(24):9631-9641. PubMed ID: 31064840
[TBL] [Abstract][Full Text] [Related]
14. Mobilization of a splicing factor through a nuclear kinase-kinase complex.
Aubol BE; Keshwani MM; Fattet L; Adams JA
Biochem J; 2018 Feb; 475(3):677-690. PubMed ID: 29335301
[TBL] [Abstract][Full Text] [Related]
15. A conserved sequence motif bridges two protein kinases for enhanced phosphorylation and nuclear function of a splicing factor.
Aubol BE; Fattet L; Adams JA
FEBS J; 2021 Jan; 288(2):566-581. PubMed ID: 32359191
[TBL] [Abstract][Full Text] [Related]
16. Regulation of influenza A virus mRNA splicing by CLK1.
Artarini A; Meyer M; Shin YJ; Huber K; Hilz N; Bracher F; Eros D; Orfi L; Keri G; Goedert S; Neuenschwander M; von Kries J; Domovich-Eisenberg Y; Dekel N; Szabadkai I; Lebendiker M; Horváth Z; Danieli T; Livnah O; Moncorgé O; Frise R; Barclay W; Meyer TF; Karlas A
Antiviral Res; 2019 Aug; 168():187-196. PubMed ID: 31176694
[TBL] [Abstract][Full Text] [Related]
17. In vivo regulation of alternative pre-mRNA splicing by the Clk1 protein kinase.
Duncan PI; Stojdl DF; Marius RM; Bell JC
Mol Cell Biol; 1997 Oct; 17(10):5996-6001. PubMed ID: 9315658
[TBL] [Abstract][Full Text] [Related]
18. Interplay between SRPK and Clk/Sty kinases in phosphorylation of the splicing factor ASF/SF2 is regulated by a docking motif in ASF/SF2.
Ngo JC; Chakrabarti S; Ding JH; Velazquez-Dones A; Nolen B; Aubol BE; Adams JA; Fu XD; Ghosh G
Mol Cell; 2005 Oct; 20(1):77-89. PubMed ID: 16209947
[TBL] [Abstract][Full Text] [Related]
19. Regulation and substrate specificity of the SR protein kinase Clk/Sty.
Prasad J; Manley JL
Mol Cell Biol; 2003 Jun; 23(12):4139-49. PubMed ID: 12773558
[TBL] [Abstract][Full Text] [Related]
20. The protein kinase Clk/Sty directly modulates SR protein activity: both hyper- and hypophosphorylation inhibit splicing.
Prasad J; Colwill K; Pawson T; Manley JL
Mol Cell Biol; 1999 Oct; 19(10):6991-7000. PubMed ID: 10490636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
